[ad_1]
A vaccinated person in Switzerland died after being inoculated with Pfizer-BioNTech serum. However, it is not known at this time if the death is related to the vaccine.
UPDATE 20:40 The Swiss Agency for Therapeutics, which is also responsible for licensing the commercialization of COVID-19 vaccines, called a link between the recent death of a 91-year-old person and their immunization with the vaccine as “highly unlikely” developed by COVID-19. Pfizer-BioNTech, AFP reports Wednesday.
“Investigations by cantonal medical authorities and Swissmedic concluded, taking into account the ailments suffered by the person and the course of his illness, that most likely there is no link between death and vaccination,” the agency said in a statement.
“The very comprehensive data currently available indicates pre-existing diseases as natural causes of death (for this patient), which was recorded on the death certificate,” says Swissmedic.
The 91-year-old patient was a resident of a nursing home and was one of the first in Switzerland to be immunized with the anti-COVID-19 vaccine developed by Pfizer (USA) and BioNTech (Germany).
The vaccine has already been given to several million people in the United Kingdom, the United States, and some European countries, without ever being associated with any deaths.
The producers emphasized in a statement that “their thoughts are with the families”, but “unfortunately deaths from unrelated vaccines occur to the same extent that they would occur in the general population of the elderly and people at risk who are a priority” in the campaigns current immunization programs.
The information about the death of the Swiss citizen initially appeared in an online article written by a controversial Swiss journalist, among others, to minimize the pandemic, and was later assumed by numerous media in the country, AFP also points out.
The patient from Switzerland was one of the first people to receive the coronavavirus vaccine, and the death was reported in the canton of Lucerne, local authorities announced Wednesday, according to Reuters and news.ro.
A spokesperson said the case was known and that the problem had been reported to Swissmedic, the drug regulator.
No details or the period from inoculation to death were provided.
The first vaccinations in Switzerland took place in Lucerne last week, and the vaccine developed by Pfizer with German partner BioNTech takes priority for the elderly.
Switzerland, which has so far only approved the use of the Pfizer / BioNTech vaccine, has received 107,000 doses and will receive 250,000 per month next year.
Pfizer and Swissmedic have yet to provide details.
Millions of doses of this vaccine have already been administered in various countries around the world. After administration, several allergic reactions occurred, as in the case of the administration of the vaccine developed by Moderna, but so far no life-threatening reactions have been recorded.
